Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MANAGED CARE FORMULARIES TO FOCUS ON 50-100 PRODUCTS WITH BEST OUTCOMES, CIGNA's PENNA PREDICTS; DRUG SPENDING RE-EMERGING AS MANAGED CARE TARGET?

Executive Summary

Managed care formularies will begin to focus more on encouraging use of 50 to 100 products, rather than attempting to create a comprehensive list of covered drugs, Cigna VP-Managed Pharmacy Peter Penna told the June Drug Information Association annual meeting in Montreal.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel